Most Popular Documents

See which documents other people are reading and reviewing most often. The list is updated on a regular basis to give you the most current information.

Displaying Most Popular Documents

31 Items

Position Statements for the Implementation of Oncology Biosimilars from the pan-Canadian Clinical Operations Working Group

Document Status: Current
Version: 1

Aug 2019

Person-Centred Virtual Cancer Care Clinical Guidance

Document Status: Current
Version: 2

Jan 2022

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

Bevacizumab for Recurrent Glioblastoma Multiforme (GBM)

Document Status: Archived
ID: CED 19

Jul 2010

Treatment of Chronic Myeloid Leukemia with Imatinib

Document Status: Archived
ID: 6-15

Dec 2013

Ibritumomab Tiuxetan in Lymphoma

Document Status: Archived
ID: 6-17

Nov 2013

Rituximab in Chronic Lymphocytic Leukemia

Document Status: Archived
ID: CED 15

Nov 2009

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Imatinib Mesylate in the Adjuvant Treatment of Gastrointestinal Stromal Tumours (GIST)

Document Status: Archived
ID: CED 17

Mar 2010

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Document Status: Archived
ID: 6-22

Jan 2007

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Document Status: Archived
ID: 6-23 (CED)

Jan 2012

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Document Status: Archived
ID: CED 8

Jul 2008